Katsutoshi Miyosawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
Journal: Cardiovascular diabetology
Published: October 26, 2023
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis.
Journal: Scientific reports
Published: November 08, 2021
Reduced Number of Platelets During Intra-Aortic Balloon Pumping Counterpulsation Predicts Higher Cardiovascular Mortality After Device Removal in Association with Systemic Inflammation.
Journal: International heart journal
Published: January 21, 2020
Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Journal: Cardiovascular diabetology
Published: November 05, 2019
A Novel Nutritional Index Serves as A Useful Prognostic Indicator in Cardiac Critical Patients Requiring Mechanical Circulatory Support.
Journal: Nutrients
Published: May 27, 2019
Promotion of oxidative stress is associated with mitochondrial dysfunction and muscle atrophy in aging mice.
Journal: Geriatrics & gerontology international
Published: May 24, 2019
Lack of IκBNS promotes cholate-containing high-fat diet-induced inflammation and atherogenesis in low-density lipoprotein (LDL) receptor-deficient mice.
Journal: International journal of cardiology. Heart & vasculature
Published: January 29, 2019
Mass spectrometry meets the challenge of understanding the complexity of the lipoproteome: recent findings regarding proteins involved in dyslipidemia and cardiovascular disease.
Journal: Expert review of proteomics
Published: September 02, 2015
New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolism.
New CETP inhibitor K-312 reduces PCSK9 expression: a potential effect on LDL cholesterol metabolism.
Journal: American journal of physiology. Endocrinology and metabolism
Published: November 17, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026